Mutation detail:
| Mutation site | P224S |
| Virus | Influenzavirus A H1N1 |
| Mutation level |
Amino acid Level |
| Gene/protein/region type | PA |
| Gene ID | 23308128 |
| Country | Canada |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | clade 1 |
| Sample |
Human |
| Variants | - |
| Viral reference sequence | FJ966081.1 |
| Drug/antibody/vaccine | - |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | - |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Polymerase PA |
| Uniprot protein ID | C3W5X6 |
| Protein length | 716 amino acids |
| Protein description | PA Plays an essential role in viral RNA transcription and replication by forming the heterotrimeric polymerase complex together with PB1 and PB2 subunits. The complex transcribes viral mRNAs by using a unique mechanism called cap-snatching. It consists in the hijacking and cleavage of host capped pre-mRNAs. These short capped RNAs are then used as primers for viral mRNAs. The PB2 subunit is responsible for the binding of the 5' cap of cellular pre-mRNAs which are subsequently cleaved after 10-13 nucleotides by the PA subunit that carries the endonuclease activity. |
Literature information:
| Pubmed ID | 21249207 |
| Clinical information | No |
| Disease | - |
| Published year | 2011 |
| Journal | PLoS One |
| Title | Nationwide molecular surveillance of pandemic H1N1 influenza A virus genomes: Canada, 2013 |
| Author | Morag Graham,Binhua Liang,Gary Van Domselaar,Nathalie Bastien,Carole Beaudoin |
| Evidence | Presence in all Canadian sequences of non-clade 1 mutations (namely HA (P83S [P100S], and I321V [I338V]) and PA (P224S)) agrees with prior reports of limited geographic dissemination of clade 1 isolates. |